These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2833302)

  • 1. Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma.
    Zaniboni A; Simoncini E; Marpicati P; Marini G
    Br J Cancer; 1988 Mar; 57(3):319. PubMed ID: 2833302
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
    Link KH; Pillasch J; Weindel M; Leder G; Beger HG
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1380. PubMed ID: 8854758
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
    Di Lorenzo G; Rea A; Carlomagno C; Pepe S; Palmieri G; Labianca R; Chirianni A; De Stefano A; Esposito V; De Placido S; Montesarchio V
    World J Gastroenterol; 2007 Dec; 13(48):6553-7. PubMed ID: 18161926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraarterial chemotherapy: another choice for unresectable advanced hepatocellular carcinoma?
    Li CP; Chao Y
    J Chin Med Assoc; 2004 Dec; 67(12):595-6. PubMed ID: 15779480
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis.
    He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M
    Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II intravenous study of epirubicin with 5-fluorouracil in patients with advanced hepatocellular carcinoma.
    Kajanti MJ; Pyrhönen SO
    Eur J Cancer; 1991; 27(12):1620-2. PubMed ID: 1664219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapy.
    Bower M; Newlands ES; Habib N
    Clin Oncol (R Coll Radiol); 1996; 8(5):331-3. PubMed ID: 8934055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
    J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B
    Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
    Samonigg H; Stöger H; Bauernhofer T; Schmid M; Kasparek AK; Kuss I; Kaul M; Heberle U; Vieder L; Dusleag J
    Am J Clin Oncol; 1990; 13 Suppl 1():S44-7. PubMed ID: 2291457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases.
    Anderson JH; Kerr DJ; Cooke TG; McArdle CS
    Br J Cancer; 1992 Jun; 65(6):913-5. PubMed ID: 1616863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of huge advanced hepatocellular carcinoma resected after hepatic arterial infusion therapy of 5-FU/LV/CDDP].
    Nakadai E; Tonouchi A; Fujita Y; Nakamura J; Nakagawa K; Miyazaki M
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1405-7. PubMed ID: 24196081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
    Lin CP; Yu HC; Cheng JS; Lai KH; Lo GH; Hsu PI; Lin CK; Chen HH; Lo CC; Liang HL; Tseng HH
    J Chin Med Assoc; 2004 Dec; 67(12):602-10. PubMed ID: 15779483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update.
    Marini G; Simoncini E; Zaniboni A; Gorni F; Marpicati P; Zambruni A
    Oncology; 1987; 44(6):336-40. PubMed ID: 3500441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
    Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
    J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
    Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
    Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma.
    Mughal TI; Koriech OM
    Acta Oncol; 1996; 35(2):248. PubMed ID: 8639324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.